X

MRK

Where does Merck (MRK) stand in the cancer-drug race?

Shares of Merck and Co. (NYSE: MRK) this week pared some of their recent gains even as the ex-dividend date…

Merck’s (MRK) Q3 results beat estimates; sales boosted by oncology and vaccines

Merck (NYSE: MRK) surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing…